FDA clears Outset Medical’s TabloCart with prefiltration for enhanced dialysis treatment

By on    Healthcare Industry News  

FDA clears Outset Medical’s TabloCart with prefiltration for enhanced dialysis treatment

Outset Medical, Inc., a leader in innovative medical technology, has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its new product, TabloCart with prefiltration. This accessory is designed to enhance the functionality of the Tablo Hemodialysis System, already known for its revolutionary approach to dialysis by reducing the procedure’s […]

Outset Medical raises $125m funding for Tablo Hemodialysis System

By on    Healthcare Industry News  

Outset Medical raises $125m funding for Tablo Hemodialysis System

US-based medical technology company Outset Medical has secured $125 million funding in a Series E financing round for the commercialization of Tablo Hemodialysis System, an enterprise solution designed to bring down the cost and complexity of dialysis. Outset Medical, based in Silicon Valley, deals with technology-driven service model innovation intended to reduce the cost and […]